6 Indian HealthTech Startups Selected for 2026 UK-India HealthTech Accelerator
The programme is being delivered in collaboration with the UK Government, Manipal Academy of Higher Education (MAHE) and Bhubaneswar City Knowledge Innovation Cluster Foundation (BCKIC).
Six Indian HealthTech and MedTech startups have been selected for the 2026 UK-India HealthTech Accelerator Programme, a UK government-backed initiative that helps Indian healthcare companies explore the UK market, engage with the NHS and build commercial, research and investment partnerships.
The six selected startups are Azooka Labs and Turtle Shell Technologies from Bengaluru, Bioscan Research and TatvaCare from Ahmedabad, OrthoHeal from Vadodara, and EzeRx Health Tech from Bhubaneswar. The cohort was announced by UK Trade Commissioner for South Asia Harjinder Kang in Bengaluru on August 27.
The programme, launched in 2023, is designed to help Indian HealthTech and MedTech companies understand the UK healthcare ecosystem, including NHS pathways, regulatory requirements and procurement processes, while providing opportunities to engage with potential customers, healthcare organisations, researchers and investors.
The 2026 edition initially brought 25 Indian HealthTech startups into a three-day accelerator programme in India. Six startups were subsequently selected for a fully funded UK immersion programme, where they will gain direct access to the wider UK HealthTech ecosystem, including NHS stakeholders, investors and potential partners.
The selected companies are working across a range of healthcare applications. Their areas include cancer drug development, therapeutic proteins, AI-enabled clinical technologies, rare-disease diagnostics, healthcare analytics and AI-powered radiology, according to programme organisers.
The programme is being delivered in collaboration with the UK Government, Manipal Academy of Higher Education (MAHE) and Bhubaneswar City Knowledge Innovation Cluster Foundation (BCKIC). The initiative is focused on connecting Indian healthcare innovators with the UK’s healthcare, research and commercial ecosystem.
The 2026 programme is the fourth edition of the accelerator. Over the four-year programme, it has attracted nearly 1,000 applications from Indian HealthTech companies, while seven companies from previous cohorts have established a presence in the UK. More than 10-15 companies have also gone on to collaborate with UK universities, NHS organisations and other innovation partners.
Across its first three editions, the programme is projected to support around 100 jobs and generate £32 million in investment and wider economic activity in the UK, according to the organisers.
The initiative comes as Indian HealthTech and MedTech startups increasingly look beyond the domestic market, particularly in areas such as artificial intelligence, diagnostics, medical devices, digital health and biotechnology. For these companies, entering the UK can provide access to the NHS as well as a large network of healthcare researchers, investors and industry partners.
For the selected startups, the UK immersion will provide an opportunity to assess market-entry strategies, understand regulatory and procurement pathways, explore potential pilots and build relationships with prospective NHS and commercial partners.